Study Claims Ozempic Lowers Biological Age
Researchers reveal that GLP-1 medication Ozempic may reduce biological age, offering new hope in the fight against aging and related health issues.
Ozempic, originally developed as a treatment for diabetes, has proven to be versatile, also treating obesity and promoting weight loss.
A 32-week, double-blind, placebo-controlled trial by TruDiagnostic suggests that Ozempic may reduce the user’s biologic age by just over three years.
GLP-1 medications have become mostly known for treating obesity and helping to promote weight loss.
The positive impact on weight-management makes the drugs helpful in treating conditions associated or impacted by obesity.
Author summary: Ozempic may reduce biological age.
More News
- Dodgers’ Freddie Freeman ends 18-inning World Series Game 3 thriller
- Lisbon’s Viral Pastel de Nata Is a Gift and a Curse
- Santa Cruz Warriors release 2025 training camp roster | NBA G League
- Benz Hui Dies At 76 from Cancer-Related Organ Failure
- The Tech Odyssey: AI, Moonshots, and Musk's Encyclopedia of Everything
- As top LDS Church leaders age, they move closer to ‘the zone of dementia’
- Giving States Waivers From Accountability Is a Dangerous Step Backward for Kids
- 400,000 Coloradans have cast votes so far
- Major Candy Company Files Chapter 11 Bankruptcy Amid Halloween Week Shock - CCE l ONLINE NEWS